Fibromyalgia of Less Than One Year Duration. Study of Pregabalin

Inclusion Criteria: * • Meet the 2010 ACR criteria for diagnosis of fibromyalgia (See Appendix) * Meet the 1990 ACR criteria for the classification of fibromyalgia (See Appendix) * Patients have a pain VAS \> 4 * Patients are able to understand and sign informed consent * Patients are able to understand and complete study questionnaires * Patients are prepared to discontinue all pain medications including non-steroidal anti-inflammatory drugs (NSAIDs), and medications for sleep or mood disturbances two weeks prior to beginning the study. Acetaminophen, up to 2 extra-strength, three times daily, will be allowed for break-through pain. Medication use will be surveyed at each visit (See Appendix). * Age - \> 18 * Females with no documented evidence of current pregnancy, and willingness to take the necessary precautions to prevent pregnancy for the duration of the study period Exclusion Criteria: * • Patients with a significant musculoskeletal or rheumatic disorder that may confuse the diagnosis * Any subject with suicidal thoughts in the past or currently * Patient with a history of renal disease, heart disease, bleeding problems or low platelet counts * Women who are breast feeding * Men or women who plan to have children during the course of the study * Unable to discontinue any medications prescribed for pain, other than acetaminophen, or any medications for sleep or mood disturbances for at least 2 weeks before the study * Unable to discontinue any mediations used for sleep disturbances * Patients currently being treated for any psychiatric illness including depression or anxiety disorder * Patients currently taking antidepressant, anti-anxiety, or antipsychotic medications. * Inability to understand and sign informed consent and complete questionnaires.